Models, signals, and distributed bio-behavioral control of exercise in diabetes
糖尿病运动的模型、信号和分布式生物行为控制
基本信息
- 批准号:8971447
- 负责人:
- 金额:$ 297.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2020-05-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAddressAdherenceAlgorithmsArchitectureArtificial PancreasAutomationBehavior ControlBlood GlucoseCarbohydratesCellular PhoneClinical TrialsComplexDataData AnalysesData CollectionDatabasesDecision Support SystemsDetectionDevelopmentDevicesDiabetes MellitusDoseEcosystemEducationEnsureExerciseExposure toFaceFeasibility StudiesFeedbackFrightGlucoseHearingHeart RateHome environmentHourHumanHyperglycemiaHypoglycemiaIllinoisInjection of therapeutic agentInpatientsInstitutesInsulinInsulin-Dependent Diabetes MellitusIntakeLeadLeftLifeMedical DeviceMetabolicModelingMonitorNamesPatientsPatternPhilosophyPhysical activityPhysiologicalPhysiologyPumpResearchResearch InfrastructureRiskRunningSafetySignal TransductionSpecificitySystemTechnologyTestingTimeUniversitiesUpdateValidationVariantVirginiabaseblood glucose regulationclinically relevantcloud baseddesigndetectorempoweredfeedingfitnessglycemic controlimprovednovelpancreas developmentprogramspsychosocialpublic health relevancesafety studysensorsimulation
项目摘要
DESCRIPTION (provided by applicant): Physically active patients with type 1 diabetes (T1D) face a very specific challenge in their management of glycaemia: physical activity can dramatically alter glucose homeostasis both acutely and over a period of several hours. The magnitude of this behaviorally triggered physiological disturbance is highly variable and depends on a number of factors such as insulin- on-board, prandial state, and fitness to name only a few. These complex interactions and associated fear of hypoglycemia often lead to avoidance of physical activity. We propose to address this specific hurdle of living with diabetes by empowering patients through a network of medical devices, assembled into an adaptive artificial pancreas (AP) platform, tailored to the needs and choices of each patient. This project unites two leading groups in artificial pancreas development, the University of Virginia Center for
Diabetes Technology and the Illinois Institute of Technology Center for Diabetes Research and Education. We propose to leverage our extensive technology portfolio in AP platform, closed loop algorithms, exercise detection and quantification, and modelling to address the following specific aims: 1. Patient-specific exercise risk alert system informing patients at the onset of exercise of likely hypoglycemia based on: (i) tuning a risk detector to each patient using DiAs cloud functionalities, and (ii) personalized simulation-based advice on treatment adaptation. 2. Exercise-informed automated insulin dosing: Upgrade to AP control system using exercise sensing to track metabolic risk and adjust insulin to maintain safe BG levels. 3. Fully-integrated Exercise-adapted AP system: We hypothesize that an exercise-informed AP system with both feed-forward (1) and feedback (2) components, freeing the patient from obligatory additional devices will improve glycemic safety and technology acceptance. We will demonstrate feasibility, safety, and efficacy of each of the proposed modules, independently and in concert, through three human clinical trials: two short term inpatient demonstration trials and one final longer term (4 months) home trial. This final trial will also explore psychosocial aspects of exercising with our platform, and start addressing key aspects of safety, accounting for adherence and technology acceptance of such a complex system. We expect the proposed system to enhance the safety and efficacy of AP in real life conditions. By creating a novel data infrastructure and optimal exercise control algorithms, this project has also the potential to generate clinically relevant derivatives for other mode of treatment.
描述(由申请人提供):经常运动的 1 型糖尿病 (T1D) 患者在血糖管理方面面临着非常特殊的挑战:体力活动可以在几个小时内急剧改变血糖稳态。引发的生理紊乱变化很大,取决于多种因素,例如胰岛素、膳食状态和健康状况等,这些复杂的相互作用和相关的低血糖恐惧常常导致回避。我们建议通过医疗设备网络为患者提供帮助,将其组装成人工适应性胰腺(AP)平台,根据每位患者的需求和选择来解决糖尿病患者的这一特定障碍。该项目由两个部分组成。弗吉尼亚大学人工胰腺开发中心的领导小组
我们建议利用糖尿病技术和伊利诺伊理工学院糖尿病研究和教育中心的广泛技术组合、闭环算法、运动检测和量化以及建模来实现以下特定目标: 1. 针对患者的特定目标。运动风险警报系统在运动开始时通知患者可能发生低血糖,其基于:(i) 使用 DiAs 云功能调整每个患者的风险检测器,以及 (ii) 基于个性化模拟的治疗适应建议 2。运动知情的自动胰岛素剂量:升级到 AP 控制系统,使用运动感应来跟踪代谢风险并调整胰岛素以维持安全的 BG 水平 3. 完全集成的运动适应 AP 系统:我们发现运动知情的 AP 系统具有两者。前馈(1)和反馈(2)组件,将患者从强制性的额外装置中解放出来,将提高血糖安全性和技术接受度,我们将通过以下方式独立和协调地证明每个提议模块的可行性、安全性和有效性。三项人体临床试验:两项短期住院示范试验和一项最终长期(4 个月)家庭试验这项最终试验还将探索使用我们的平台锻炼的心理社会方面,并开始解决安全、依从性和技术等关键方面。我们期望所提出的系统能够通过创建新颖的数据基础设施和最佳运动控制算法来增强 AP 在现实生活中的安全性和有效性,该项目还有可能为其他系统生成临床相关的衍生产品。治疗方式。
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
Improving Glucose Prediction Accuracy in Physically Active Adolescents With Type 1 Diabetes.
提高患有 1 型糖尿病的体力活跃青少年的血糖预测准确性。
- DOI:
- 发表时间:2019
- 期刊:
- 影响因子:0
- 作者:Hobbs, Nicole;Hajizadeh, Iman;Rashid, Mudassir;Turksoy, Kamuran;Breton, Marc;Cinar, Ali
- 通讯作者:Cinar, Ali
Anticipation of Historical Exercise Patterns by a Novel Artificial Pancreas System Reduces Hypoglycemia During and After Moderate-Intensity Physical Activity in People with Type 1 Diabetes.
新型人工胰腺系统对历史运动模式的预测可减少 1 型糖尿病患者中等强度体力活动期间和之后的低血糖。
- DOI:
- 发表时间:2021
- 期刊:
- 影响因子:5.4
- 作者:Garcia;Brown, Sue A;Laichuthai, Nitchakarn;Colmegna, Patricio;Koravi, Chaitanya L K;Ozaslan, Basak;Corbett, John P;Barnett, Charlotte L;Pajewski, Michael;Oliveri, Mary C;Myers, Helen;Breton, Marc D
- 通讯作者:Breton, Marc D
Closed-Loop Control with Unannounced Exercise for Adults with Type 1 Diabetes using the Ensemble Model Predictive Control.
使用集成模型预测控制对 1 型糖尿病成人进行突击锻炼闭环控制。
- DOI:10.1016/j.jprocont.2019.05.017
- 发表时间:2019-08-01
- 期刊:
- 影响因子:4.2
- 作者:J. Garcia;John P. Corbett;Dimitri Boiroux;J. B. Jørgensen;M. Breton
- 通讯作者:M. Breton
Combining Short-Term Interval Training with Caloric Restriction Improves ß-Cell Function in Obese Adults.
将短期间歇训练与热量限制相结合可改善肥胖成人的细胞功能。
- DOI:
- 发表时间:2018-06-03
- 期刊:
- 影响因子:5.9
- 作者:Francois, Monique E;Gilbertson, Nicole M;Eichner, Natalie Z M;Heiston, Emily M;Fabris, Chiara;Breton, Marc;Mehaffey, J Hunter;Hassinger, Taryn;Hallowell, Peter T;Malin, Steven K
- 通讯作者:Malin, Steven K
Impact of short-term exercise training intensity on β-cell function in older obese adults with prediabetes.
短期运动训练强度对老年肥胖糖尿病前期患者β细胞功能的影响。
- DOI:
- 发表时间:2018-12-01
- 期刊:
- 影响因子:0
- 作者:Malin, Steven K;Francois, Monique E;Eichner, Natalie Z M;Gilbertson, Nicole M;Heiston, Emily M;Fabris, Chiara;Breton, Marc
- 通讯作者:Breton, Marc
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARC D BRETON其他文献
MARC D BRETON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARC D BRETON', 18)}}的其他基金
Advanced Artificial Pancreas Systems to Enable Fully Automated Glycemic Control in Type 1 Diabetes Mellitus
先进的人工胰腺系统可实现 1 型糖尿病的全自动血糖控制
- 批准号:
10488207 - 财政年份:2021
- 资助金额:
$ 297.99万 - 项目类别:
Translation of the UVA Advanced Automated Insulin Delivery Systems to Clinical Care in Young Children: Glycemic Control, Regulatory Acceptance and Optimization of Day to Day Use
UVA 先进自动胰岛素输送系统在幼儿临床护理中的应用:血糖控制、监管接受和日常使用优化
- 批准号:
10474818 - 财政年份:2021
- 资助金额:
$ 297.99万 - 项目类别:
Advanced Artificial Pancreas Systems to Enable Fully Automated Glycemic Control in Type 1 Diabetes Mellitus
先进的人工胰腺系统可实现 1 型糖尿病的全自动血糖控制
- 批准号:
10276560 - 财政年份:2021
- 资助金额:
$ 297.99万 - 项目类别:
Advanced Artificial Pancreas Systems to Enable Fully Automated Glycemic Control in Type 1 Diabetes Mellitus
先进的人工胰腺系统可实现 1 型糖尿病的全自动血糖控制
- 批准号:
10676903 - 财政年份:2021
- 资助金额:
$ 297.99万 - 项目类别:
Advanced Artificial Pancreas Systems to Enable Fully Automated Glycemic Control in Type 1 Diabetes Mellitus
先进的人工胰腺系统可实现 1 型糖尿病的全自动血糖控制
- 批准号:
10676903 - 财政年份:2021
- 资助金额:
$ 297.99万 - 项目类别:
Translation of the UVA Advanced Automated Insulin Delivery Systems to Clinical Care in Young Children: Glycemic Control, Regulatory Acceptance and Optimization of Day to Day Use
UVA 先进自动胰岛素输送系统在幼儿临床护理中的应用:血糖控制、监管接受和日常使用优化
- 批准号:
10470808 - 财政年份:2020
- 资助金额:
$ 297.99万 - 项目类别:
Artificial Pancreas - Adolescent Physiology and Psychology Longitudinal Evaluation (A.P. APPLE)
人工胰腺 - 青少年生理学和心理学纵向评估 (A.P. APPLE)
- 批准号:
10381710 - 财政年份:2020
- 资助金额:
$ 297.99万 - 项目类别:
Translation of the UVA Advanced Automated Insulin Delivery Systems to Clinical Care in Young Children: Glycemic Control, Regulatory Acceptance and Optimization of Day to Day Use
UVA 先进自动胰岛素输送系统在幼儿临床护理中的应用:血糖控制、监管接受和日常使用优化
- 批准号:
10265602 - 财政年份:2020
- 资助金额:
$ 297.99万 - 项目类别:
Artificial Pancreas - Adolescent Physiology and Psychology Longitudinal Evaluation (A.P. APPLE)
人工胰腺 - 青少年生理学和心理学纵向评估 (A.P. APPLE)
- 批准号:
10597623 - 财政年份:2020
- 资助金额:
$ 297.99万 - 项目类别:
FEASIBILITY STUDY OF A MODULAR CONTROL TO RANGE SYSTEM IN T1DM
T1DM 测距系统模块化控制的可行性研究
- 批准号:
8167201 - 财政年份:2010
- 资助金额:
$ 297.99万 - 项目类别:
相似国自然基金
巨噬细胞Nogo-B通过FABP4/IL-18/IL-18R调控急性肝衰竭的分子机制研究
- 批准号:82304503
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α7nAChR激动剂通过PGC-1α和HO-1调控肾小管上皮细胞线粒体的质和量进而改善脓毒症急性肾损伤的机制研究
- 批准号:82372172
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于解郁散热“把好气分关”探讨代谢-炎症“开关”A2BR在急性胰腺炎既病防变中的作用与机制
- 批准号:82374256
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
RacGAP1介导细胞核-线粒体对话在急性肾损伤中促进肾小管上皮细胞能量平衡的作用机制研究
- 批准号:82300771
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
开窍寒温配伍调控应激颗粒铁离子富集水平抗急性缺血性卒中铁死亡损伤的机制研究
- 批准号:82374209
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 297.99万 - 项目类别:
3/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)
3/4-美国早期肝移植联盟-前瞻性酒精相关性肝病队列评估(ACCELERATE-PACE)
- 批准号:
10711001 - 财政年份:2023
- 资助金额:
$ 297.99万 - 项目类别:
Achieving Health Equity During the COVID-19 Pandemic: Lessons Learned from Nurses and High Performing Hospitals
在 COVID-19 大流行期间实现健康公平:从护士和高绩效医院汲取的经验教训
- 批准号:
10655888 - 财政年份:2023
- 资助金额:
$ 297.99万 - 项目类别:
Development of Patient-Tailored Adaptive Treatment Strategies for Acute Severe Ulcerative Colitis
制定针对急性重症溃疡性结肠炎的患者定制适应性治疗策略
- 批准号:
10569397 - 财政年份:2023
- 资助金额:
$ 297.99万 - 项目类别: